+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Exosome Diagnostic and Therapeutic Global Market Report 2024

  • PDF Icon

    Report

  • 175 Pages
  • February 2024
  • Region: Global
  • The Business Research Company
  • ID: 5895239
The exosome diagnostic and therapeutic market size has grown exponentially in recent years. It will grow from $0.36 billion in 2023 to $0.48 billion in 2024 at a compound annual growth rate (CAGR) of 31.1%. The growth observed in the historical period can be attributed to several key factors. These include significant advancements in biological research, the emergence and development of precision medicine approaches, innovations in biomedical imaging technologies, a strong focus on cancer research and advancements in oncology, and substantial investments made within the healthcare industry. These factors collectively contributed to the growth and progress witnessed during the historical period in the field of exosome diagnostics and therapeutics.

The exosome diagnostic and therapeutic market size is expected to see exponential growth in the next few years. It will grow to $1.28 billion in 2028 at a compound annual growth rate (CAGR) of 28.1%. The anticipated growth in the forecasted period can be attributed to several contributing factors. These include the increasing adoption of exosome-based clinical applications, the integration of exosomes with digital health technologies, a supportive regulatory environment fostering advancements, the rise of gene editing and RNA therapeutics furthering exosome research, and the expanded role of exosomes in immuno-oncology applications. Key trends expected in this forecasted period encompass the utilization of exosomes in drug discovery processes, innovative approaches in biomimetic exosome engineering, commercialization initiatives for exosome-based products, leveraging exosomes as carriers for therapeutic cargo, and the use of exosome-based liquid biopsy methods for cancer screening. These trends are projected to significantly influence and drive the growth of exosome diagnostics and therapeutics in the forecasted period.

The anticipated growth of the exosome diagnostic and therapeutic market is strongly driven by the increasing prevalence of chronic diseases. Chronic illnesses, lasting three months or more and prone to deterioration over time, are a significant health concern globally. Exosomes, utilized in both diagnostic and therapeutic capacities, emerge as promising biomarkers in cancer, enabling more sensitive disease monitoring and facilitating the accessibility of personalized medicine. In a projection from January 2023, the National Center for Biotechnology Information (NCBI) indicates a forecasted global count of 142.66 million individuals with chronic diseases by 2050. This statistic underscores the pivotal role played by the rising prevalence of chronic diseases in propelling the exosome diagnostics and therapeutics market.

The upward trajectory of the exosome diagnostic and therapeutic market is further fueled by the increasing size of the geriatric population. The term 'geriatric population' refers to individuals aged 65 years and older, often in the later stages of life. This demographic expansion contributes significantly to the demand for exosome diagnostics and therapeutics, as exosomes serve as valuable tools for diagnosing and addressing age-related conditions. Notably, a report from the World Health Organization (WHO) in October 2022 indicates a profound demographic shift, with one in six individuals projected to be 60 or older by 2030 globally. By 2050, an estimated 2.1 billion people worldwide will be 60 years old or older. This demographic shift underscores the substantial impact of the rising geriatric population on driving the growth of the exosome diagnostic and therapeutic market.

Major companies are actively engaged in developing innovative products, such as sample purification systems, to expand their customer base, boost sales, and drive revenue growth. A sample purification system encompasses a suite of processes and technologies designed to eliminate impurities and contaminants from various sample types, including DNA, RNA, proteins, and other biomolecules. As an illustration, in February 2023, Biological Dynamics Inc., a prominent US-based biotechnology company, introduced ExoVerita - an exosome-isolation platform designed for early disease surveillance and diverse applications. The ExoVita Pancreas assay, part of this platform, identifies specific exosomal protein indicators and has demonstrated the ability to detect Stage 1 and Stage 2 pancreatic ductal adenocarcinoma (PDAC) using blood-based exosome samples enriched on the patented ExoVerita apparatus. The company is actively validating these findings through the ExoLuminate registry trial (NCT05625529), recruiting high-risk PDAC patients to assess the clinical value of the test.

Major players in the exosome diagnostic and therapeutic market are adopting a strategic partnership approach to enhance the exosome purification process. Strategic partnerships involve companies leveraging each other's strengths and resources for mutual benefits and success. A noteworthy example is the collaboration between Cytiva, a prominent US-based biotechnology company, and RoosterBio Inc., also a US-based biotechnology company. Announced in October 2023, this partnership aims to improve the exosome purification process, a current bottleneck hindering the widespread adoption of promising gene therapies and other innovative modalities. By combining the strengths of both entities, the collaboration seeks to address a significant challenge limiting the use of exosomes in therapeutic applications, particularly as carriers for gene therapies and biologics. The envisioned outcome is the advancement of large-scale manufacturing capabilities for exosomes.

In November 2021, Lonza Group AG, a renowned Switzerland-based company specializing in contract manufacturing and development solutions, successfully acquired an exosome manufacturing facility from Codiak BioSciences Inc. for a sum of $65 million. This strategic acquisition by Lonza is intended to broaden its scope of services, encompassing exosome assay and process development, analytics, and manufacturing services. Moreover, Lonza seeks to expedite advancements in exosome production, purification, and analytics through this acquisition. Codiak BioSciences Inc., a US-based clinical-stage biopharmaceutical company, is known for its expertise in developing exosome-based therapeutics.

Major companies operating in the exosome diagnostic and therapeutic market report are Thermo Fisher Scientific Inc., Lonza Group AG, Bio-Techne Corp., Miltenyi Biotec GmBH, Malvern Instruments Inc., BioVision Inc., System Biosciences LLC, Evox Therapeutics Ltd., ExCoBio Inc., BioCat GmbH, NanoSomix Inc. , Exosome Diagnostics Inc., Capricor Therapeutic Inc., Aethlon Medical Inc., Codiak BioSciences Inc., NX Pharmagen Inc., Exiqon A/S, Aegle Therapeutic Corporation, AMS Biotechnology Ltd., Cell Guidance Systems, Ciloa, Sienna Diagnostics, Sistemic Inc., Theoria Science, Mantra Bio Inc.

North America was the largest region in the exosome diagnostic and therapeutic market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the exosome diagnostic and therapeutic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the exosome diagnostic and therapeutic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The primary products within the exosome diagnostic and therapeutic market comprise instruments, software, reagents, and kits. Instruments refer to equipment utilized for precise and accurate execution of activities or experiments. These products find diverse applications in diagnostics and therapeutics and cater to various end-users, including academic and research institutes, pharmaceutical and biotechnology companies, hospitals and clinics, among others.

The exosome diagnostic and therapeutic market research report is one of a series of new reports that provides exosome diagnostic and therapeutic market statistics, including exosome diagnostic and therapeutic industry global market size, regional shares, competitors with an exosome diagnostic and therapeutic market share, detailed exosome diagnostic and therapeutic market segments, market trends and opportunities, and any further data you may need to thrive in the exosome diagnostic and therapeutic industry. This exosome diagnostic and therapeutic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The exosome diagnostic and therapeutic market consists of revenues earned by entities by providing services such as genomic sequencing, exome sequencing, resequencing, and targeted sequencing. The market value includes the value of related goods sold by the service provider or included within the service offering. The exosome diagnostic and therapeutic market also includes sales of exosome-based assays, exosome flow cytometry kits, and protein biomarker detection kits, which are used in providing exosome-based drug delivery services. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).


The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. Exosome Diagnostic and Therapeutic Market Characteristics3. Exosome Diagnostic and Therapeutic Market Trends and Strategies
4. Exosome Diagnostic and Therapeutic Market - Macro Economic Scenario
4.1. Impact of High Inflation on the Market
4.2. Ukraine-Russia War Impact on the Market
4.3. COVID-19 Impact on the Market
5. Global Exosome Diagnostic and Therapeutic Market Size and Growth
5.1. Global Exosome Diagnostic and Therapeutic Market Drivers and Restraints
5.1.1. Drivers of the Market
5.1.2. Restraints of the Market
5.2. Global Exosome Diagnostic and Therapeutic Historic Market Size and Growth, 2018-2023, Value ($ Billion)
5.3. Global Exosome Diagnostic and Therapeutic Forecast Market Size and Growth, 2023-2028, 2033F, Value ($ Billion)
6. Exosome Diagnostic and Therapeutic Market Segmentation
6.1. Global Exosome Diagnostic and Therapeutic Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Instruments
  • Software
  • Reagents and Kits
6.2. Global Exosome Diagnostic and Therapeutic Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Diagnostics
  • Therapeutic
6.3. Global Exosome Diagnostic and Therapeutic Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Hospitals and Clinics
  • Other End Users
7. Exosome Diagnostic and Therapeutic Market Regional and Country Analysis
7.1. Global Exosome Diagnostic and Therapeutic Market, Split by Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Exosome Diagnostic and Therapeutic Market, Split by Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Exosome Diagnostic and Therapeutic Market
8.1. Asia-Pacific Exosome Diagnostic and Therapeutic Market Overview
Region Information, Impact of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Exosome Diagnostic and Therapeutic Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Exosome Diagnostic and Therapeutic Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Exosome Diagnostic and Therapeutic Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Exosome Diagnostic and Therapeutic Market
9.1. China Exosome Diagnostic and Therapeutic Market Overview
9.2. China Exosome Diagnostic and Therapeutic Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Exosome Diagnostic and Therapeutic Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Exosome Diagnostic and Therapeutic Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Exosome Diagnostic and Therapeutic Market
10.1. India Exosome Diagnostic and Therapeutic Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Exosome Diagnostic and Therapeutic Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Exosome Diagnostic and Therapeutic Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Exosome Diagnostic and Therapeutic Market
11.1. Japan Exosome Diagnostic and Therapeutic Market Overview
11.2. Japan Exosome Diagnostic and Therapeutic Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Exosome Diagnostic and Therapeutic Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Exosome Diagnostic and Therapeutic Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Exosome Diagnostic and Therapeutic Market
12.1. Australia Exosome Diagnostic and Therapeutic Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Exosome Diagnostic and Therapeutic Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Exosome Diagnostic and Therapeutic Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Exosome Diagnostic and Therapeutic Market
13.1. Indonesia Exosome Diagnostic and Therapeutic Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Exosome Diagnostic and Therapeutic Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Exosome Diagnostic and Therapeutic Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Exosome Diagnostic and Therapeutic Market
14.1. South Korea Exosome Diagnostic and Therapeutic Market Overview
14.2. South Korea Exosome Diagnostic and Therapeutic Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Exosome Diagnostic and Therapeutic Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Exosome Diagnostic and Therapeutic Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Exosome Diagnostic and Therapeutic Market
15.1. Western Europe Exosome Diagnostic and Therapeutic Market Overview
15.2. Western Europe Exosome Diagnostic and Therapeutic Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Exosome Diagnostic and Therapeutic Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Exosome Diagnostic and Therapeutic Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Exosome Diagnostic and Therapeutic Market
16.1. UK Exosome Diagnostic and Therapeutic Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Exosome Diagnostic and Therapeutic Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Exosome Diagnostic and Therapeutic Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Exosome Diagnostic and Therapeutic Market
17.1. Germany Exosome Diagnostic and Therapeutic Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Exosome Diagnostic and Therapeutic Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Exosome Diagnostic and Therapeutic Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Exosome Diagnostic and Therapeutic Market
18.1. France Exosome Diagnostic and Therapeutic Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Exosome Diagnostic and Therapeutic Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Exosome Diagnostic and Therapeutic Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Exosome Diagnostic and Therapeutic Market
19.1. Italy Exosome Diagnostic and Therapeutic Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Exosome Diagnostic and Therapeutic Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Exosome Diagnostic and Therapeutic Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Exosome Diagnostic and Therapeutic Market
20.1. Spain Exosome Diagnostic and Therapeutic Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Exosome Diagnostic and Therapeutic Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Exosome Diagnostic and Therapeutic Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Exosome Diagnostic and Therapeutic Market
21.1. Eastern Europe Exosome Diagnostic and Therapeutic Market Overview
21.2. Eastern Europe Exosome Diagnostic and Therapeutic Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Exosome Diagnostic and Therapeutic Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Exosome Diagnostic and Therapeutic Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Exosome Diagnostic and Therapeutic Market
22.1. Russia Exosome Diagnostic and Therapeutic Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Exosome Diagnostic and Therapeutic Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Exosome Diagnostic and Therapeutic Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Exosome Diagnostic and Therapeutic Market
23.1. North America Exosome Diagnostic and Therapeutic Market Overview
23.2. North America Exosome Diagnostic and Therapeutic Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Exosome Diagnostic and Therapeutic Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Exosome Diagnostic and Therapeutic Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Exosome Diagnostic and Therapeutic Market
24.1. USA Exosome Diagnostic and Therapeutic Market Overview
24.2. USA Exosome Diagnostic and Therapeutic Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Exosome Diagnostic and Therapeutic Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Exosome Diagnostic and Therapeutic Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Exosome Diagnostic and Therapeutic Market
25.1. Canada Exosome Diagnostic and Therapeutic Market Overview
25.2. Canada Exosome Diagnostic and Therapeutic Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Exosome Diagnostic and Therapeutic Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Exosome Diagnostic and Therapeutic Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Exosome Diagnostic and Therapeutic Market
26.1. South America Exosome Diagnostic and Therapeutic Market Overview
26.2. South America Exosome Diagnostic and Therapeutic Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Exosome Diagnostic and Therapeutic Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Exosome Diagnostic and Therapeutic Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Exosome Diagnostic and Therapeutic Market
27.1. Brazil Exosome Diagnostic and Therapeutic Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Exosome Diagnostic and Therapeutic Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Exosome Diagnostic and Therapeutic Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Exosome Diagnostic and Therapeutic Market
28.1. Middle East Exosome Diagnostic and Therapeutic Market Overview
28.2. Middle East Exosome Diagnostic and Therapeutic Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Exosome Diagnostic and Therapeutic Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Exosome Diagnostic and Therapeutic Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Exosome Diagnostic and Therapeutic Market
29.1. Africa Exosome Diagnostic and Therapeutic Market Overview
29.2. Africa Exosome Diagnostic and Therapeutic Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Exosome Diagnostic and Therapeutic Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Exosome Diagnostic and Therapeutic Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Exosome Diagnostic and Therapeutic Market Competitive Landscape and Company Profiles
30.1. Exosome Diagnostic and Therapeutic Market Competitive Landscape
30.2. Exosome Diagnostic and Therapeutic Market Company Profiles
30.2.1. Thermo Fisher Scientific Inc.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Lonza Group AG
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Bio-Techne Corp.
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Miltenyi Biotec GmBH
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Malvern Instruments Inc.
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Exosome Diagnostic and Therapeutic Market Other Major and Innovative Companies
31.1. BioVision Inc.
31.2. System Biosciences LLC
31.3. Evox Therapeutics Ltd.
31.4. ExCoBio Inc.
31.5. BioCat GmbH
31.6. NanoSomix Inc.
31.7. Exosome Diagnostics Inc.
31.8. Capricor Therapeutic Inc.
31.9. Aethlon Medical Inc.
31.10. Codiak BioSciences Inc.
31.11. NX Pharmagen Inc.
31.12. Exiqon A/S
31.13. Aegle Therapeutic Corporation
31.14. AMS Biotechnology Ltd.
31.15. Cell Guidance Systems
32. Global Exosome Diagnostic and Therapeutic Market Competitive Benchmarking33. Global Exosome Diagnostic and Therapeutic Market Competitive Dashboard34. Key Mergers and Acquisitions in the Exosome Diagnostic and Therapeutic Market
35. Exosome Diagnostic and Therapeutic Market Future Outlook and Potential Analysis
35.1 Exosome Diagnostic and Therapeutic Market in 2028 - Countries Offering Most New Opportunities
35.2 Exosome Diagnostic and Therapeutic Market in 2028 - Segments Offering Most New Opportunities
35.3 Exosome Diagnostic and Therapeutic Market in 2028 - Growth Strategies
35.3.1 Market Trend-based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic and Forecast Inflation Rates
36.4. Research Inquiries
36.5. About the Analyst
36.6. Copyright and Disclaimer

Executive Summary

Exosome Diagnostic and Therapeutic Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on exosome diagnostic and therapeutic market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia-Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis.
  • Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for exosome diagnostic and therapeutic? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? This report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
  • The impact of higher inflation in many countries and the resulting spike in interest rates.
  • The continued but declining impact of COVID-19 on supply chains and consumption patterns.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Report Scope

Markets Covered:
1) By Product: Instruments; Software; Reagents and Kits
2) By Application: Diagnostics; Therapeutic
3) By End-user: Academic and Research Institutes; Pharmaceutical and Biotechnology Companies; Hospitals and Clinics; Other End-users

Key Companies Mentioned: Thermo Fisher Scientific Inc.; Lonza Group AG; Bio-Techne Corp.; Miltenyi Biotec GmBH; Malvern Instruments Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes

Delivery Format: PDF, Word and Excel Data Dashboard

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Thermo Fisher Scientific Inc.
  • Lonza Group AG
  • Bio-Techne Corp.
  • Miltenyi Biotec GmBH
  • Malvern Instruments Inc.
  • BioVision Inc.
  • System Biosciences LLC
  • Evox Therapeutics Ltd.
  • ExCoBio Inc.
  • BioCat GmbH
  • NanoSomix Inc.
  • Exosome Diagnostics Inc.
  • Capricor Therapeutic Inc.
  • Aethlon Medical Inc.
  • Codiak BioSciences Inc.
  • NX Pharmagen Inc.
  • Exiqon A/S
  • Aegle Therapeutic Corporation
  • AMS Biotechnology Ltd.
  • Cell Guidance Systems
  • Ciloa
  • Sienna Diagnostics
  • Sistemic Inc.
  • Theoria Science
  • Mantra Bio Inc.

Methodology

Loading
LOADING...

Table Information